Imperagen raises 5 million to use quantum physics, AI on enzyme engineering | TechCrunch

Imperagen, founded in 2021 by Manchester Institute of Biotechnology scientists, raised a £5 million seed round led by PXN Ventures with participation from IQ Capital and Northern Gritstone. The company aims to improve enzyme engineering by making it faster, more efficient, and less costly than current trial-and-error lab mutation approaches. Imperagen uses quantum physics-based simulation to predict enzyme variant behavior and explore millions of mutations on a computer. It converts simulation outputs into custom AI models trained on enzyme problems the company targets. Robots and automation generate experimental data that feeds back into the AI model through closed-loop simulation. Enzymes are important for pharmaceuticals and other industries, and faster engineering can speed drug discovery and support more sustainable industrial manufacturing.

"Imperagen is using three core technologies as it seeks to redefine enzyme engineering. Specifically, it uses a quantum physics-based simulation instead of trial-and-error enzyme mutations in a lab. Imperagen predicts the behavior of enzyme variants on a computer using advanced quantum physics modeling that can explore millions of mutations, the company said. Then it translates this information into its custom AI models, trained on the enzyme problems Imperagen seeks to explore."

"Finally, to retain its AI models, Imperagen uses robots and automation to generate experimental data, which is fed back to the AI model, in a process called closed-loop simulation. Enzymes are incredibly important across many industries, especially in pharmaceuticals, as they are essential to drug development. Startups like Imperagen are hoping to speed up enzyme engineering because it can have a domino effect, making, for example, drug discovery faster and more efficient."

"The startup seeks to improve enzyme engineering by making it faster, more efficient, and less costly than the slower, more physical, trial-and-error-focused process used now. Imperagen is using three core technologies as it seeks to redefine enzyme engineering. Specifically, it uses a quantum physics-based simulation instead of trial-and-error enzyme mutations in a lab."

"Enzymes are also used in sectors like food, biofuels, and agriculture. Experts in sustainability are also looking to enzymes - and the AI technologies surrounding them - to make industrial production and manufacturing more sustainable. Others in this space include Biomatter, Cradle Bio, and Absci."

Read at TechCrunch